UK Markets open in 6 hrs 7 mins

CureVac N.V. (CVAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
18.73-0.68 (-3.50%)
At close: 04:00PM EDT
18.73 0.00 (0.00%)
After hours: 07:25PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3125.66
52-week low 314.20
50-day moving average 317.53
200-day moving average 334.39

Share statistics

Avg vol (3-month) 3518.41k
Avg vol (10-day) 3678.95k
Shares outstanding 5187.05M
Implied shares outstanding 6N/A
Float 885.7M
% held by insiders 152.59%
% held by institutions 123.31%
Shares short (28 Apr 2022) 47.66M
Short ratio (28 Apr 2022) 416.02
Short % of float (28 Apr 2022) 410.62%
Short % of shares outstanding (28 Apr 2022) 44.09%
Shares short (prior month 30 Mar 2022) 46.8M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,022.58%

Management effectiveness

Return on assets (ttm)-49.31%
Return on equity (ttm)-58.82%

Income statement

Revenue (ttm)102.99M
Revenue per share (ttm)0.55
Quarterly revenue growth (yoy)582.40%
Gross profit (ttm)-135.09M
EBITDA -1.04B
Net income avi to common (ttm)-411.72M
Diluted EPS (ttm)-2.87
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)811.46M
Total cash per share (mrq)4.34
Total debt (mrq)28.89M
Total debt/equity (mrq)4.20
Current ratio (mrq)2.63
Book value per share (mrq)3.72

Cash flow statement

Operating cash flow (ttm)-733.13M
Levered free cash flow (ttm)-713.37M